Controlled absorption diltiazem pharmaceutical formulation
View Patent ↗A controlled absorption diltiazem pellet formulation for oral administration comprises a core having diltiazem or a pharmaceutically acceptable salt thereof as the active ingredient. The core is surrounded by a coating which has only a single layer which is comprised of a relatively major proportion of talc and relatively minor proportion of sodium lauryl sulfate admixed with a minor proportion of a pharmaceutically acceptable film-forming, first polymer permeable to water and diltiazem, and a major proportion of a pharmaceutically acceptable film-forming, second polymer that is less permeable to water and diltiazem than the first polymer. The core and the coating layer both exclude organic acids. The composition of the coating layer as well as the proportion of core to coating layer are effective to permit release of the diltiazem allowing controlled absorption following oral administration. By combining short lag and long lag pellets into a single formulation, the release of diltiazem is controlled over a twenty four hour period.
1. A long lag pellet suitable for use in a once-a-day diltiazem formulation comprising a core and a coating layer sufficiently enveloping the core, wherein
1) the core comprises an effective amount of diltiazem or a pharmaceutically acceptable salt and is substantially free of organic acid; and
2) the long lag pellet substantially exhibits the following dissolution profile when measured according to U.S. Pharmacopoeia XXII in a type 2 dissolution apparatus at 37° C. in 0.1N HCl at 100 rpm;
a) 0 to 10% of the diltiazem is released after 2 hours;
b) 0 to 10% of the diltiazem is released after 4 hours;
c) 0 to 15% of the diltiazem is released after 6 hours;
d) 0 to 15% of the diltiazem is released after 8 hours;
e) 4.5% to 24.5% of the diltiazem is released after 14 hours;
f) 41% to 61% of the diltiazem is released after 16 hours; and
g) more than 60% of the diltiazem is released after 18 hours.
2. A long lag pellet suitable for use in a once-a-day diltiazem formulation comprising a core and a coating layer sufficiently enveloping the core, wherein
1) the core comprises an effective amount of diltiazem or a pharmaceutically acceptable salt and is substantially free of organic acid; and
2) the long lag pellet substantially exhibits the following dissolution profile when measured according to U.S. Pharmacopoeia XXII in a type 2 dissolution apparatus at 37° C. in 0.1N HCl at 100 rpm;
a) 0 to 10.3% of the diltiazem is released after 2 hours;
b) 0 to 10.5% of the diltiazem is released after 4 hours;
c) 0 to 10.7% of the diltiazem is released after 6 hours;
d) 0 to 10.9% of the diltiazem is released after 8 hours;
e) 4.5% to 24.5% of the diltiazem is released after 14 hours;
f) 41% to 61% of the diltiazem is released after 16 hours; and
g) more than 60% of the diltiazem is released after 18 hours.
3. A once-a-day diltiazem formulation for oral administration comprising a mixture of two types of pellets, one of which is a long lag pellet that comprises a core and a coating layer sufficiently enveloping the core, wherein
1) the core comprises an effective amount of diltiazem or a pharmaceutically acceptable salt and is substantially free of organic acid; and
2) the long lag pellet substantially exhibits the following dissolution profile when measured according to U.S. Pharmacopoeia XXII in a type 2 dissolution apparatus at 37° C. in 0.1N HCl at 100 rpm;
a) 0 to 10% of the diltiazem is released after 2 hours;
b) 0 to 10% of the diltiazem is released after 4 hours;
c) 0 to 15% of the diltiazem is released after 6 hours;
d) 0 to 15% of the diltiazem is released after 8 hours;
e) 4.5% to 24.5% of the diltiazem is released after 14 hours;
f) 41% to 61% of the diltiazem is released after 16 hours; and
g) more than 60% of the diltiazem is released after 18 hours.
4. A once-a-day diltiazem formulation for oral administration comprising a mixture of two types of pellets one of which is a long lag pellet that comprises a core and a coating layer sufficiently enveloping the core, wherein
1) the core comprises an effective amount of diltiazem or a pharmaceutically acceptable salt and is substantially free of organic acid; and
2) the long lag pellet substantially exhibits the following dissolution profile when measured according to U.S. Pharmacopoeia XXII in a type 2 dissolution apparatus at 37° C. in 0.1N HCl at 100 rpm;
a) 0 to 10.3% of the diltiazem is released after 2 hours;
b) 0 to 10.5% of the diltiazem is released after 4 hours;
c) 0 to 10.7% of the diltiazem is released after 6 hours;
d) 0 to 10.9% of the diltiazem is released after 8 hours;
e) 4.5% to 24.5% of the diltiazem is released after 14 hours;
f) 41% to 61% of the diltiazem is released after 16 hours; and
g) more than 60% of the diltiazem is released after 18 hours.
5. A long lag pellet according to claims 1 through 4 where 14.5% to 24.5% of the diltiazem is released after 14 hours.
6. A long lag pellet according to claims 1 through 4 where 51% to 61% of the diltiazem is released after 16 hours.
7. A long lag pellet according to claims 1 through 4 where 41% to 51% of the diltiazem is released after 16 hours.
8. A long lag pellet according to claims 1 through 4 where 14.5% to 24.5% of the diltiazem is released after 14 hours and 51% to 61% of the diltiazem is released after 16 hours.
9. A long lag pellet according to claims 1 through 4 where 14.5% to 24.5% of the diltiazem is released after 14 hours and 41% to 51% of the diltiazem is released after 16 hours.
10. A long lag pellet according to claims 1 through 4 where
a) 0-10.3% of the diltiazem is released after 1 hour;
b) 0-11.3% of the diltiazem is released after 10 hours; and
c) 0-13.1% of the diltiazem is released after 12 hours.
11. A long lag pellet according to claims 1 through 4 where
a) 0-10.3% of the diltiazem is released after 1 hour;
b) 0-11.3% of the diltiazem is released after 10 hours;
c) 0-13.1% of the diltiazem is released after 12 hours;
d) 14.5% to 24.5% of the diltiazem is released after 14 hours; and
e) 51% to 61% of the diltiazem is released after 16 hours.